Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
CIN.AX
7.54%
▲ 2.73%
HGH.AX
177.66%
▼ -8.62%
Gross Margin
CIN.AX
100.00%
HGH.AX
47.45%
▼ -0.33%
Free Cash Flow
CIN.AX
$12.44M
▼ -$3.46M
HGH.AX
-$45.81M
▼ -$11.31M
Net Debt / EBITDA
CIN.AX
-0.20
▲ 0.02
HGH.AX
2.07
▲ 1.18
Operating Margin
CIN.AX
98.03%
▲ 0.42%
HGH.AX
18.53%
▼ -1.46%
P/E Ratio
CIN.AX
12.16
▲ 0.45
HGH.AX
7.71
▼ -0.97